drugset / Trial / NCT06289920

A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fasting Conditions in Healthy Adult Volunteers

NCT06289920 ↗

Phase 1 Completed 47 enrolled Boryung Pharmaceutical Co., Ltd
RandomizedCrossoverOpen-labelTreatment

Summary

The objective of this clinical study is to compare the pharmacokinetics and the safety between a fixed-dose combination administration of "BR3005" and co-administration of "BR3005-1" and "BR3005-2" under fasting conditions in healthy adult volunteers

Timeline

Start
2024-03-02
Primary completion
2024-03-28
Completion
2024-03-28

Drugs

EvaluationDrugModalityDoseRoute
Subject BR3005 Unknown — —
Comparator BR3005-1 Unknown — —
Comparator BR3005-2 Unknown — —